SampsonUKNormanPEFowkesFG. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):171–180.e10.
2.
GolledgeJMullerJDaughertyANormanP. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26(12):2605–2613.
3.
GolledgeJNormanPE. Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients’ management. Curr Opin Cardiol. 2009;24(6):532–538.
4.
GolledgeJNormanPE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011;217(1):57–63.
5.
GolledgeJNormanPE. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?Arterioscler Thromb Vasc Biol. 2010;30(6):1075–1077.
6.
ShahBRockmanCBGuoY. Diabetes and vascular disease in different arterial territories. Diabetes Care. 2014;37(6):1636–1642.
7.
De RangoPFarchioniLFiorucciBLentiM. Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014;47(3):243–261.
8.
TakagiHUmemotoT. Diabetes and abdominal aortic aneurysm growth [published online August 25, 2015]. Angiology. 2015. doi:10.1177/0003319715602414
9.
GolledgeJKaranMMoranCS. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008;29(5):665–672.
10.
ThompsonSGBrownLCSweetingMJ. Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol Assess. 2013;17(41):1–118.
11.
TsaiCLLinCLWuYYShiehDCSungFCKaoCH. Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study. Diabetes Metab Res Rev. 2015;31(2):190–197.
12.
TheivacumarNSStephensonMAMistryHValentiD. Diabetes mellitus and aortic aneurysm rupture: a favorable association?Vasc Endovascular Surg. 2014;48(1):45–50.
13.
ThompsonACooperJAFabriciusMHumphriesSEAshtonHAHafezH. An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg. 2010;52(1):55–61.
14.
LeMTJamrozikKDavisTMNormanPE. Negative association between infrarenal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg. 2007;33(5):599–604.
15.
TeschGH. Role of macrophages in complications of type 2 diabetes. Clin Exp Pharmacol Physiol. 2007;34(10):1016–1019.
16.
DuaMMMiyamaNAzumaJ. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery. 2010;148(2):429–435.
17.
KowluruRAZhongQSantosJM. Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9. Expert Opin Investig Drugs. 2012;21(6):797–805.
18.
NormanPEDavisTMLeMTGolledgeJ. Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res. 2007;48(3):125–131.
19.
CandidoRJandeleit-DahmKACaoZ. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 2002;106(2):246–253.
20.
PhamYTuYWuT. Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis. Diabetologia. 2010;53(1):170–179.
21.
DeclevesAESharmaK. Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nat Rev Nephrol. 2014;10(5):257–267.
22.
HagiwaraSKantharidisPCooperME. What are new avenues for renal protection, in addition to RAAS inhibition?Curr Hypertens Rep. 2012;14(2):100–110.
23.
SillesenHEldrupNHultgrenR; AORTA Trial Investigators. Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br J Surg. 2015;102(8):894–901.
24.
MeijerCAStijnenTWasserMNHammingJFvan BockelJHLindemanJH; Pharmaceutical Aneurysm Stabilisation Trial Study Group. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann Intern Med. 2013;159(12):815–823.
